Sign in

CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
460571712
Phone
484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes Chief Business Officer gave up 5,937 shares (to pay taxes)
  6. 4 Shares withheld for taxes CEO gave up 18,611 shares (to pay taxes)
  7. 4 Option exercise President and COO acquired 18,675 shares (option exercise)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 6,449 shares (to pay taxes)
  9. 4/A Shares withheld for taxes Chief Business Officer gave up 10,686 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 4,984 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Business Officer gave up 15,980 shares (to pay taxes)
  12. 4/A Shares withheld for taxes Chief Business Officer gave up 15,980 shares (to pay taxes)
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 8-K Event Regulation FD disclosure
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 8-K Event Regulation FD disclosure · Other events
  17. 4 Shares withheld for taxes CEO gave up 9,952 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Business Officer gave up 40,165 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 26,645 shares (to pay taxes)
  20. 4 Option exercise President and COO acquired 26,750 shares (option exercise)

Page 3 of 44 · 872 filings